Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Unless some folks got their head in their A$$ they'll miss out...I'll add more and more my investments are no risk / no rewards.
In the next few days I'll be adding more a few million more...
Making the case why early detection with Fire Fly would have avoided hospitals etc from lawsuits....
http://news.yahoo.com/ebola-victims-family-agreement-hospital-160714403.html
http://news.yahoo.com/obama-seeks-open-internet-us-rules-150510247.html;_ylt=AwrBEiS3smNUjXIAWibQtDMD
Obama endorsed an effort to reclassify the Internet as a public utility to give regulators authority to enforce "net neutrality," the principle barring Internet service firms from playing favorites or opening up "fast lanes" for those who pay more.In a statement, Obama said he wants the independent Federal Communications Commission to "implement the strongest possible rules to protect net neutrality."
Obama's comment comes as the FCC seeks to draft new rules to replace those struck down this year by a US appeals court, which said the agency lacked authority to regulate Internet service firms as it does telephone carriers.
"'Net neutrality' has been built into the fabric of the Internet since its creation -- but it is also a principle that we cannot take for granted," Obama said in a statement.
"We cannot allow Internet service providers to restrict the best access or to pick winners and losers in the online marketplace for services and ideas."
Obama said that while the FCC is an independent agency, he wants the regulatory body to maintain key principles of net neutrality.
He said the rules should ensure no blocking of any legal content, to ensure that an Internet provider does not shut out a service such as Netflix to promote a rival one.
.. View gallery
Network cables are plugged in a server room on November …
Network cables are plugged in a server room on November 10, 2014 in New York (AFP Photo/Michael Bocc …
Obama seeks to ban "paid prioritization" that would allow one service to get into a faster lane by paying extra, or the flip side of that, which would be "throttling" or slowing a service which does not pay.
- No 'gatekeeping' -
"No service should be stuck in a 'slow lane' because it does not pay a fee," Obama said.
Obama also said he wants the same rules to apply to mobile broadband, which was not covered in the earlier regulations.
To accomplish this, Obama said the rules should reclassify consumer broadband service as a public utility -- a move that has been fiercely opposed by the companies that would be affected.
The FCC is redrafting its rules after the court decision struck down its regulations in a case brought by US broadband giant Verizon.
Obama's plan puts him squarely in the camp of consumer activists and many tech firms, such as Google and Microsoft, which have endorsed net neutrality.
.. View gallery
L-R: FCC Commissioner Ajit Pai, Commissioner Mignon …
L-R: FCC Commissioner Ajit Pai, Commissioner Mignon Clyburn, FCC Chairman Tom Wheeler, Jessica Rosen …
Ed Black at the Computer & Communications Industry Association, which represents major tech firms, said Obama's plan "is the best legal strategy if the much needed open Internet rules are to be effective."
- Political fight looms -
But Obama's move swiftly drew fire from Republican lawmakers, who said the proposal amounts to old-style regulation.
Senate Republican leader Mitch McConnell said Obama's approach smacks of "heavy-handed regulation that will stifle innovation and concentrate more power in the hands of Washington bureaucrats."
Senator Ted Cruz said the plan "puts the government in charge of determining Internet pricing, terms of service, and what types of products and services can be delivered, leading to fewer choices, fewer opportunities, and higher prices for consumers."
Will Marshall, president of the Progressive Policy Institute, said Obama appears to be girding for a fight with Republicans despite the sweeping victory for the opposition in last week's midterm elections.
"The president's statement is exactly the wrong reaction to the election. It endorses a backward-looking policy that would apply the brakes to the most dynamic sector of America’s economy," Marshall said.
Scott Belcher, who heads the Telecommunications Industry Association, said the reclassification "would set the industry back decades, and threaten the private sector investment that is critically needed to ensure that the network can meet surging demand."
Walter McCormick at the US Telecom Association said Obama's proposal would be "a shift that will redefine the Internet, insert the government deeply into its management and invite other countries to do the same."
Others welcomed the initiative.
Nuala O’Connor, president of the Center for Democracy and Technology, said the proposals "is one way to ensure everyone has equal access and the opportunity to thrive in the digital economy."
The consumer group Common Cause said the plan would "preserve the innovative capacity of the Internet and ensure that its transformative power extends to all consumers -- not just those who can afford a fast lane."
FCC chairman Tom Wheeler welcomed Obama's statement but offered no timetable for the new rules.
"Like the president, I believe that the Internet must remain an open platform... We both oppose Internet fast lanes," Wheeler said in a statement.
But he noted that reclassification poses "substantive legal questions," and that the agency needs time "to ensure that whatever approach is taken, it can withstand any legal challenges it may face."
Psid Going places soon —$1.83 billion for the CDC, to be divided between fighting the epidemic in West Africa, ramping up U.S. preparedness and global health security — helping other vulnerable countries build the health systems and train their workers to spot and respond to early signs of outbreaks.
—On the domestic front, the CDC would support more than 50 hospitals around the country designated as being capable of safely treating Ebola cases, train health workers and health departments how to screen for Ebola and handle suspect and confirmed cases, and buy protective equipment for the national stockpile.
—Also included is $238 million for the National Institutes of Health for clinical trials of experimental vaccines and treatments.
—The U.S. Agency for International Development and State Department would receive about $2 billion to further scale up assistance in West Africa.
With the recent news of net neutrality WLAN may very well be poised for dominance in it's space could very well see this market exploding with Netflix, amazon, apple, google, ultraflix, hbo, cbs,etc.. all needing to stream their shows.
http://www.wialan.com/assets/WT-VOD.pdf
Adding cameras with face recognizing software on the device would also be a plus..makes it easy to id anyone who may have been tested such as an ebola case anywhere afterwards
The objective of this Agreement is to provide a foundation for cooperative work between USSOCOM SORDAC-ST and PositiveID to continue the development of Firefly Dx for Special Operations Force ("SOF") applications, and to provide enhanced operational capability to USSOCOM assets. PositiveID will receive requirements, priorities, feedback, and human factors/human systems integration support to facilitate its ability to support SOF technology needs.
Don't forget also Satcom on FIRE FLY
Makes sense to add Wi-Fi to further develop the Company's real-time PCR (polymerase chain reaction) pathogen detection system, Firefly Dx, for use across the USSOCOM mission space.
by taking advantage of the TaqMan based PCR assay and real-time detection, the Firefly Dx system can be adapted to measure altered gene expression levels such as those observed in endocrine diseases, radiation exposure, and cancer. Results can be immediately obtained and processed in situ via SMART phone interface (or personal computer) with a specialized, mobile application and Cloud based data sharing and storage.
Adding Wi-Fi to air play data and securely transmit? The system is a two-part device consisting of a portable handheld instrument with wireless Bluetooth communication and disposable single-use cartridges containing all necessary analytical elements.
Scams do not have products and distribution centers selling it and consumers buying their products. Right Now you can make a purchase of Marani Vodka from Costco, Total Wines etc drink it Holidays will be here soon Timing is everything.
Someone is getting the ball rolling they're getting off their A$$ES and doing something finally with FIREFLY DX.
Firefly Dx is being developed to meet the growing need in military and healthcare markets for more rapid and accurate point-of-need diagnostics that will enable hospitals, physicians, deployed military personnel, and others to save lives. Firefly Dx is designed to derive results from a sample in less than 20 minutes, at the point of need,
I say the ball is rolling
Dr. Patel is Director of Clinical Regenerative Medicine and Tissue Engineering at the University of Utah and has been involved in over 17 FDA trials in the area of cellular therapy. Dr. Patel currently holds more than $7 million in research grants for basic and clinical research in the area of regenerative medicine.
"It is my honor to continue working with Dr. Patel. At our previous work in Medistem, Dr. Patel was critical in initiation and execution of clinical trials, which led to the eventual sale of the company to Intrexon, a NYSE traded company," said Dr. Thomas Ichim, Ph.D., Chief Scientific Officer of Regen BioPharma. "Dr. Patel's expertise in the area of adipose stem cells will greatly add to our HemaXellerate program, which utilizes adipose tissue as starting material. Additionally, his overall familiarity with commercialization of cellular therapy products will accelerate our ongoing efforts in the development of the dCellVax breast cancer vaccine."
http://www.marketwatch.com/investing/stock/xon
Margins should increase with this news this is a game changer in their business model
The Company continues to make progress executing its strategic plan. The company will unveil its new and improved healthy menu, which it will roll out at its corporate location within in the next few weeks. The menu is the result of a months long effort with this assistance of the Company's Senior Medical Advisor, Dr. Paul Aoun. In addition, the new menu will now incorporate beer, wine and a line of margaritas and other wine base mixed drinks which the Company believes should add increased sales revenues.
http://theextinctionprotocol.wordpress.com/2014/11/04/workers-warn-ebola-in-sierra-leone-is-spreading-nine-times-faster-than-two-months-ago/
The clock is ticking for a rapid solution
$$$$$$$we are confident moving forward to the FDA in requesting permission to initiate human trials through the IND mechanisms," said Thomas Ichim, Ph.D., Chief Scientific Officer of Regen BioPharma.
This is proof for all the naysayers$$$$$$$$$$$$$$In the press release of Aug 1st, 2014 the Company reported successful silencing of the IDO gene in human dendritic cells (DC) treated with newly developed proprietary gene-silencing technology which was in part licensed from Benitec Biopharma. Today the Company reports that dCellVax generated according to the protocols that will be submitted to the FDA was capable of potently stimulating human T cells to kill breast cancer cells.
THE GRAVITY OF THIS NEWS IS RGBP WILL SHOW THE WORLD THAT IT HAS WHAT IT TAKES TO CURE CANCER$$$$$$$$$$$$$$$$$
The proposed trial will recruit 10 patients with metastatic breast cancer and will involve 4 monthly injections of the dCellVax gene-silenced dendritic cell therapy. WHICH BY THE WAY KILLS THE TUMOR ALREADY PROVEN
The trial will last one year, with tumor assessment before therapy and at 6 and 12 months.
HUGE NEWS$$$$$$
Tue, Nov 4, 2014, 9:55AM EST - US Markets close in 6 hrs and 5 mins
Recent
% | $
BMSN +37.50%
MRIB 0.00%
More ? Pop Out
Finance Home
My Portfolio
Market Data
Yahoo Originals
Business & Finance
Personal Finance
CNBC
Contributors
Recommended Games
[City of Steam Arkadia]
[Jackpot Party Casino Slots]
[Bingo USA]
More games »
Compare Brokers
FDA Issues IND Number for Regen BioPharma's dCellVax Therapeutic Application, a Proposed Treatment for Breast Cancer
SAN DIEGO, CA--(Marketwired - Nov 4, 2014) - Regen BioPharma, Inc. (OTCBB: RGBP) announced today issuance of IND (Investigational New Drug Application) number 16200 from the FDA for a proposed Phase I/II clinical trial assessing safety with signals of efficacy of the dCellVax gene silenced dendritic cell immunotherapy for treating breast cancer.
The proposed trial will recruit 10 patients with metastatic breast cancer and will involve 4 monthly injections of the dCellVax gene-silenced dendritic cell therapy. The trial will last one year, with tumor assessment before therapy and at 6 and 12 months.
Regen's dCellVax therapy is based on US Patent # 8,389,708, acquired from Professor Wei-Ping Min at the University of Western Ontario, Canada, as well as a collaboration between Dr. Min and the Company's Chief Science Officer Dr. Thomas Ichim. Preclinical studies have demonstrated efficacy in mouse models of breast cancer and melanoma.
"We see the granting of an IND number as an important first step in the clinical development of this new personalized therapy that will hopefully add a new treatment option to patients without the horrific side effects of chemotherapies," said Dr. Ichim.
Dr. Ichim further noted, "As part of the clinical trial approval process, we do anticipate comments from the FDA on our application, which will follow a similar pattern to our previous IND application for which a number was issued for our first immunotherapeutic product, HemaXellerate. Once all of the FDA comments are addressed, the Company aims to initiate gene silencing immunotherapy for Metastatic Breast Cancer Patients."
dCellVax is manufactured by generating a potent type of immune system cell, the dendritic cell, from patient's own blood. The dendritic cells are subsequently made resistant to the immune suppressive effects of the tumor by silencing the gene indolamine 2,3 deoxyagenase, technology that was licensed from Benitec BioPharma. Advantages of cancer immune therapies include: a) lack of toxicity; b) ability to attack tumor metastasis; and c) generation of immunological memory, which protects the body from recurrence of the tumor.
"I'm extremely excited about the foundation that was laid by Dr. Wei-Ping Min and his academic research leading to our dCellVax therapeutic, along with the accomplishments of Dr. Ichim and his research team in taking the first step in moving dCellVax from an academic concept to a potential drug in development," said David Koos, Chairman & CEO of Regen BioPharma. "While we are beginning with breast cancer, this first trial will serve as validation of our platform, which can be expanded into other tumor types."
About Regen BioPharma Inc.: Regen BioPharma Inc. (OTCBB: RGBP) is a majority owned subsidiary of Bio-Matrix Scientific Group, Inc. (PINKSHEETS: BMSN). Regen is a biotechnology company focused on identifying undervalued regenerative medicine applications in the stem cell space and rapidly advancing these technologies through pre-clinical and Phase I/ II clinical trials.
Currently the Company is focused on developing treatments for Aplastic Anemia and a gene silencing therapy for treating cancer. For more information refer to the company's website http://www.regenbiopharma.com/
Disclaimer: This news release may contain forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.
Contact:
Regen BioPharma Inc.
David R. Koos, PhD
Chairman & Chief Executive Officer
Phone: 619-702-1404
Looking for cheap shares to buy or cover the clock is ticking don't say I didn't warn anyone
UltraFlix has gone viral $$$$http://www.livesamachar.in/technology/tis-the-season-to-buy-4k/
Ultra flix mentioned in Fox News Report http://www.foxnews.com/tech/2014/10/31/tis-season-to-buy-4k/?
Squeeeeze time WARNING WARNING IF YOU'VE SHORTED NTEK which some have done time to cover
More NEWS$$$$$
https://gigaom.com/2014/10/29/ruckus-launches-its-first-small-business-router-could-this-be-googles-new-wi-fi-hardware/
WARNING SHORTS TIME TO COVER THIS WILL RUN AND BURN YOU.
NEW$$
https://gigaom.com/2013/05/15/ruckus-wireless-designs-an-open-wi-fi-hotspot-with-a-secure-connection/?utm_medium=content&utm_campaign=syndication&utm_source=yfinance&utm_content=ruckus-launches-its-first-small-business-router-could-this-be-googles-new-wi-fi-hardware_884506
WARNING SHORTS TIME TO COVER
Warning warning shorts Mrib is about pullout all the stops on all those who shorted it's stock
Shorts got called out cover cover cover squeezzeee
FIRE FLY DX PROGRAM Fast Tracked Aug. 22, 2014 Using the know-how gained from the M-Band project, Probst said PositiveID raised $2 million from a classified government program that he wouldn't name plus $1.5 million raised internally to begin downsizing M-Band into the Firefly prototype. That process began three years ago, and the current version of the prototype was substantially readied more than a year ago.
Oct. 10, 2014 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID") (PSID), a developer of biological detection and diagnostics solutions, today announced that it, in conjunction with its partner, ENSCO, Inc., has been awarded a SenseNet Program contract from the U.S. Department of the Interior on behalf of the U.S. Department of Homeland Security Science & Technology Directorate. The goal of this SenseNet award is to implement faster, less expensive bio-threat detection systems, using existing infrastructure where possible, to provide an added level of security.
Sept. 23, 2014 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (PSID), a developer of biological detection and diagnostics solutions, today announced that it is accelerating the prototype development of its Firefly Dx system, a handheld, real-time PCR (polymerase chain reaction) system designed to provide molecular diagnostic results in less than 20 minutes at the point of need. To advance the development, PositiveID has engaged Infinite Vision, an engineering development and contract manufacturing firm specializing in medical and biotech products.
Oct. 16, 2014 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (PSID), a developer of biological detection and diagnostics solutions, today announced that its President, Lyle L. Probst, was featured on Fox Business' The Willis Report yesterday to discuss how the Company's point-of-need pathogen detection system, Firefly Dx, could be used anywhere to detect Ebola within minutes.
Lyle also states that no hurdle needs to be overcome
Mass production of Fire FLY is Under way Congress and Whitehouse CDC, FDA, DHS, DOD all fast track early detection as public outcry will only increase with more Ebola cases this is the perfect storm and the perfect stock.
This is the NEW$$$$$$ HOLES IN THE System we NEEED FIRE FLY DX NOW ON THE GROUND.
http://video.foxnews.com/v/3855963789001/doctor-in-new-york-city-tests-positive-for-ebola/#sp=watch-live
MASS PRODUCTION NEEDS TO be speeded up.
The suspected cases after Firefly DX Detection at point should then be directed to an Ebola ready Containment center and treated.
not be sent away and told to self -monitor (who came up with this protocol needs to be fired on the spot for causing more spread of the virus.
Every First Responder needs a FIRE FLY DX IN THEIR hands Their safety is of utmost to defending against EBOLA or any other Threat
Every point of entry needs a detection system Fire Fly Along with MBand in place all travelers need to give enough time for a Test the biggest travel season is upon us we cannot drop the ball.
We need to Scream at CONGRESS and The White House To get with it sending a small crew to address Ebola is not helping we need a nation wide preparedness A rollout of FIRE FLY DX and Containment centers for any suspected with virus that's how you'll get in front of this.
Ebola is one of the drivers of psid How? the more it exposes the holes in the FR###INg system and why the Govt needs to act swiftly after all they did to not spend the money on the infrastructure of the security system for BIO-Threats to secure the country.
Look for the 52 wk high test SADAAMMMMM!!!